Taken together, the flux-constraint perspective reframes GLP-1RA therapy as a systemic metabolic state in which therapeutic durability depends on maintaining proportionality between oxidative throughput and substrate-supported regenerative capacity
Some studies show no change in GSH status upon supplementation of oral glutathione (reduced form) in healthy subjects
Despite its peptide nature, which often poses bioavailability challenges, Epitalon has been reported in some sources to exhibit resistance to hydrolysis, suggesting potential for oral uptake under specific conditions [1,4, 10]
Intestinal absorption occurs predominantly in the small bowel through active transport systems, specifically mediated by organic cation transporters (OCTN family)
Melo D, Ribeiro S, Santos-Silva A, Rocha S